Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato

Nature Medicine

Volumn 4, Issue 5, 1998, Pages 607-609

  Tacket, Carol O ^a   Mason, Hugh S ^b   Losonsky, Genevieve ^a   Clements, John D ^c   Levine, Myron M ^a   Arntzen, Charles J ^b  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b Boyce Thompson Institute for Plant Research   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; DNA; ENTEROTOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; VACCINE;

ADULT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENETIC ENGINEERING; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; MUCOSAL IMMUNITY; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; POTATO; PRIORITY JOURNAL; TRANSGENIC PLANT; VACCINATION; VACCINE PRODUCTION;

BACTERIA (MICROORGANISMS); SOLANUM TUBEROSUM;

EID: 0031863854     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0598-607     Document Type: Article

References (15)

1. Tacket, C.O. et al. Comparison of the safety and immunogenicity of aroC aroD and cya crp Salmonella typhi strains in adult volunteers. Infect. Immun. 60, 536-541 (1992).
2. Tacket, C.O. et al. Initial safety and immunogenicity studies of an oral recombinant adenohepatitis vaccine. Vaccine 10, 673-676 (1992).
3. Tacket, C.O. et al. Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres. Vaccine 12, 1270-1274 (1994).
4. Edelman, R. In: New Generation Vaccines, 2nd Edn (eds Levine M.M., Woodrow G.C., Kaper J.B., Cobon G.S.) 173-192 (Marcel Dekker, New York, 1997).
5. Mason, H.S., Lam, D.M-K. & Arntzen, C. Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl. Acad. Sci. USA 89, 11745-11749 (1992).
6. Thanavala, Y., Yang, Y.-F., Lyons, P., Mason, H.S. & Arntzen, C. Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc. Natl. Acad. Sci. USA 92, 3358-3361 (1995).
7. Haq, T.A., Mason, H.S., Clements, J.D. & Arntzen, C.J. Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 268, 714-716 (1995).
8. Mason, H.S., Haq, T.A., Clements, J.D. & Arntzen, C.J. Edible vaccine protects mice against E. coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine (in the press).
9. Arakawa, T., Chong, D.K.X. & Langridge, W.H.R. Efficacy of a food plant-based oral cholera toxin B subunit vaccine. Nature Biotech. 16, 292-297 (1998).
10. Mason, H.S. et al. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc. Natl. Acad. Sci. USA 93, 5335-5340 (1996).
11. Sixma, T.K. et al. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature 351, 371-377 (1991).
12. Black, R.E. et al. Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin. Infect. Immun. 55, 1116-1120 (1987).
13. Van de Verg, L. et al. Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei. Infect. Immun. 58, 2002-2004 (1990).
14. Levine, M.M., Young, C.R., Black, R.E., Takeda, Y. & Finkelstein, R.A. Enzyme-linked immunosorbent assay to measure antibodies to purified heat-labile enterotoxins from human and porcine strains of Escherichia coli and to cholera toxin: application in serodiagnosis and seroepidemiology. J. Clin. Microbiol. 21, 174-179 (1995).
15. Sack, D.A. & Sack, R.B. Test for enterotoxigenic Escherichia coli using Y1 adrenal cells in miniculture. Infect. Immun. 11, 334 (1975).